HCPCS Level II code J1096 designates a lacrimal ophthalmic insert delivering dexamethasone 0.1 mg, a topical corticosteroid formulation for sustained ocular administration. This product-level drug code matters nationally as it identifies a specific ophthalmic therapeutic option used in eye care for controlling inflammation, ensuring billing clarity for clinics and pharmacies that dispense or place ophthalmic inserts.

Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, payer coverage considerations, and the clinical and billing context for use in ambulatory ophthalmology settings. The publication outlines common modifiers and coding practice elements, summarizes typical sites of service, and highlights where data is not available in the input.

Intended for coding professionals, billing managers, and eye care clinicians, the report provides benchmarks, policy updates, and clinical context related to HCPCS Level II code J1096. It clarifies which stakeholders are typically involved in coverage decisions and what information to expect when submitting claims for a lacrimal dexamethasone insert.